These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31779696)

  • 21. HORYZONS trial: protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis services.
    Alvarez-Jimenez M; Bendall S; Koval P; Rice S; Cagliarini D; Valentine L; D'Alfonso S; Miles C; Russon P; Penn DL; Phillips J; Lederman R; Wadley G; Killackey E; Santesteban-Echarri O; Mihalopoulos C; Herrman H; Gonzalez-Blanch C; Gilbertson T; Lal S; Chambers R; Daglas-Georgiou R; Latorre C; Cotton SM; McGorry PD; Gleeson JF
    BMJ Open; 2019 Feb; 9(2):e024104. PubMed ID: 30782893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial.
    Gaughran F; Stringer D; Berk M; Smith S; Taylor D; Whiskey E; Landau S; Murray R; McGuire P; Gardner-Sood P; Wojewodka G; Ciufolini S; Jordan H; Clarke J; Allen L; Krivoy A; Stubbs B; Lowe P; Arbuthnott M; Rathod S; Boardman A; Firdosi M; McGrath JJ
    Trials; 2020 Jan; 21(1):14. PubMed ID: 31907006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of cognitive function in schizophrenia with
    Yolland COB; Phillipou A; Castle DJ; Neill E; Hughes ME; Galletly C; Smith ZM; Francis PS; Dean OM; Sarris J; Siskind D; Harris AWF; Rossell SL
    Nutr Neurosci; 2020 Feb; 23(2):139-148. PubMed ID: 29847303
    [No Abstract]   [Full Text] [Related]  

  • 24. Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol).
    Ellegaard PK; Licht RW; Poulsen HE; Nielsen RE; Berk M; Dean OM; Mohebbi M; Nielsen CT
    Int J Bipolar Disord; 2018 Apr; 6(1):11. PubMed ID: 29619634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
    O'Donnell CP; Allott KA; Murphy BP; Yuen HP; Proffitt TM; Papas A; Moral J; Pham T; O'Regan MK; Phassouliotis C; Simpson R; McGorry PD
    J Clin Psychiatry; 2016 Dec; 77(12):e1610-e1617. PubMed ID: 27835719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study.
    Ellegaard PK; Licht RW; Nielsen RE; Dean OM; Berk M; Poulsen HE; Mohebbi M; Nielsen CT
    J Affect Disord; 2019 Feb; 245():1043-1051. PubMed ID: 30699846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).
    Lennox B; Yeeles K; Jones PB; Zandi M; Joyce E; Yu LM; Tomei G; Pollard R; Vincent SA; Shimazaki M; Cairns I; Dowling F; Kabir T; Barnes TRE; Lingford Hughes A; Hosseini AA; Harrower T; Buckley C; Coles A
    Trials; 2019 Jun; 20(1):331. PubMed ID: 31174586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial.
    Mascayano F; Bello I; Andrews H; Arancibia D; Arratia T; Burrone MS; Conover S; Fader K; Jorquera MJ; Gomez M; Malverde S; Martínez-Alés G; Ramírez J; Reginatto G; Restrepo-Henao A; Rosencheck RA; Schilling S; Smith TE; Soto-Brandt G; Tapia E; Tapia T; Velasco P; Wall MM; Yang LH; Cabassa LJ; Susser E; Dixon L; Alvarado R
    Trials; 2022 Sep; 23(1):751. PubMed ID: 36064643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial.
    Skvarc DR; Dean OM; Byrne LK; Gray LJ; Ives K; Lane SE; Lewis M; Osborne C; Page R; Stupart D; Turner A; Berk M; Marriott AJ
    Trials; 2016 Aug; 17():395. PubMed ID: 27502769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What support of young presenting a first psychotic episode, when schooling is being challenged?].
    Vacheron MN; Veyrat-Masson H; Wehbe E
    Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD.
    Kanaan RA; Oliver G; Dharan A; Sendi S; Maier A; Mohebbi M; Ng C; Back SE; Kalivas P; Berk M
    Psychiatry Res; 2023 Sep; 327():115398. PubMed ID: 37540942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early intervention for psychosis.
    Marshall M; Rathbone J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive effects of adjunctive N-acetyl cysteine in psychosis.
    Rapado-Castro M; Dodd S; Bush AI; Malhi GS; Skvarc DR; On ZX; Berk M; Dean OM
    Psychol Med; 2017 Apr; 47(5):866-876. PubMed ID: 27894373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS).
    Pyle M; Broome MR; Joyce E; MacLennan G; Norrie J; Freeman D; Fowler D; Haddad PM; Shiers D; Hollis C; Smith J; Liew A; Byrne RE; French P; Peters S; Hudson J; Davies L; Emsley R; Yung A; Birchwood M; Longden E; Morrison AP
    Trials; 2019 Jul; 20(1):395. PubMed ID: 31272477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specialised early intervention teams for recent-onset psychosis.
    Puntis S; Minichino A; De Crescenzo F; Cipriani A; Lennox B; Harrison R
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013288. PubMed ID: 33135811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidant treatments for schizophrenia.
    Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.